| Malignant disease | |||||
|---|---|---|---|---|---|
| Malignant disease / Antibody responsive malignancy | |||||
| atezolizumab [Specialist drug] | Formulary |
NICE TA525 NICE TA739 NICE TA520 NICE TA584 NICE TA705 NICE TA1071 NICE TA638 NICE TA639 NICE TA666 |
|||
| bevacizumab [Specialist drug] | Restricted |
NICE TA118 NICE TA212 NICE TA242 NICE TA178 NICE TA214 NICE TA263 NICE TA284 NICE TA285 NICE TA666 NICE TA946 NICE TA1022 |
|||
| brentuximab vedotin [Specialist drug] | Formulary |
NICE TA478 NICE TA641 NICE TA524 NICE TA1059 NICE TA577 |
|||
| cetuximab [Specialist drug] | Formulary |
NICE TA145 NICE TA473 NICE TA242 NICE TA439 NICE TA668 |
|||
| daratumumab | Formulary |
NICE TA763 NICE TA783 NICE TA897 NICE TA917 NICE TA959 |
|||
| dostarlimab [Specialist drug] | Formulary |
NICE TA779 NICE TA1064 |
|||
| durvalumab [Specialist drug] | Restricted |
NICE TA798 NICE TA1030 NICE TA1041 NICE TA1099 NICE TA944 NICE TA1090 |
|||
| elranatamab [Specialist drug] | Restricted |
NICE TA1023 |
|||
| epcoritamab [Specialist drug] | Restricted |
NICE TA954 |
|||
| gemtuzumab ozogamicin [Specialist drug] | Formulary |
NICE TA545 |
|||
| glofitamab [Specialist drug] | Restricted |
NICE TA927 |
|||
| ipilimumab [Specialist drug] | Formulary |
NICE TA268 NICE TA319 NICE TA400 NICE TA716 NICE TA1065 NICE TA724 NICE TA780 NICE TA818 |
|||
| loncastuximab tesirine [Specialist drug] | Restricted |
NICE TA947 |
|||
| nivolumab [Specialist drug] | Formulary |
NICE TA384 NICE TA400 NICE TA684 NICE TA417 NICE TA780 NICE TA964 NICE TA462 NICE TA655 NICE TA713 NICE TA724 NICE TA876 NICE TA530 NICE TA817 NICE TA707 NICE TA746 NICE TA857 NICE TA865 NICE TA716 NICE TA1065 NICE TA736 NICE TA818 |
|||
| obinutuzumab [Specialist drug] | Formulary |
NICE TA343 NICE TA513 NICE TA629 |
|||
| panitumumab [Specialist drug] | Formulary |
NICE TA242 NICE TA439 |
|||
| pembrolizumab [Specialist drug] | Restricted |
NICE TA357 NICE TA366 NICE TA766 NICE TA837 NICE TA428 NICE TA531 NICE TA683 NICE TA770 NICE TA1017 NICE TA1037 NICE TA692 NICE TA1097 NICE TA772 NICE TA540 NICE TA967 NICE TA650 NICE TA830 NICE TA858 NICE TA661 NICE TA709 NICE TA914 NICE TA983 NICE TA737 NICE TA997 NICE TA801 NICE TA851 NICE TA939 NICE TA904 NICE TA1092 |
|||
| pertuzumab [Specialist drug] | Formulary |
NICE TA424 NICE TA509 NICE TA569 |
|||
| pertuzumab with trastuzumab [Specialist drug] | Formulary | ||||
| polatuzumab vedotin [Specialist drug] | Formulary |
NICE TA649 NICE TA874 |
|||
| rituximab | Formulary |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
| sacituzumab govitecan [Specialist drug] | Restricted |
NICE TA819 |
|||
| trastuzumab [Specialist drug] | Formulary |
NICE TA34 NICE TA257 NICE TA509 NICE TA208 |
|||
| trastuzumab deruxtecan [Specialist drug] | Formulary |
NICE TA704 NICE TA862 NICE TA992 |
|||
| trastuzumab emtansine [Specialist drug] | Formulary |
NICE TA458 NICE TA632 |
|||
| Malignant disease / Immunotherapy responsive malignancy | |||||
| lenalidomide [Specialist drug] | Formulary |
NICE TA322 NICE TA171 NICE TA586 NICE TA587 NICE TA627 NICE TA680 |
|||
| mifamurtide [Specialist drug] | Formulary |
NICE TA235 |
|||
| pomalidomide [Specialist drug] | Formulary |
NICE TA427 |
|||
| thalidomide [Specialist drug] | Formulary |
NICE TA228 |
|||
| Malignant disease / Targeted therapy responsive malignancy | |||||
| abemaciclib [Specialist drug] | Formulary |
NICE TA563 NICE TA725 NICE TA810 |
|||
| acalabrutinib [Specialist drug] | Formulary |
NICE TA689 NICE TA689 |
|||
| afatinib [Specialist drug] | Formulary |
NICE TA310 |
|||
| aflibercept [Specialist drug] | Non-Formulary |
NICE TA294 NICE TA305 NICE TA346 NICE TA409 NICE TA486 NICE TA307 |
|||
| alectinib [Specialist drug] | Restricted |
NICE TA536 NICE TA1014 |
|||
| alpelisib [Specialist drug] | Formulary |
NICE TA816 |
|||
| bortezomib [Specialist drug] | Formulary |
NICE TA370 NICE TA311 NICE TA228 NICE TA129 |
|||
| bosutinib [Specialist drug] | Formulary |
NICE TA401 |
|||
| capivasertib [Specialist drug] | Restricted |
NICE TA1063 |
|||
| carfilzomib [Specialist drug] | Formulary |
NICE TA657 NICE TA695 |
|||
| ceritinib [Specialist drug] | Formulary |
NICE TA395 NICE TA500 |
|||
| crizotinib [Specialist drug] | Formulary |
NICE TA406 NICE TA422 NICE TA1021 |
|||
| dabrafenib [Specialist drug] | Formulary |
NICE TA321 NICE TA396 NICE TA544 NICE TA898 |
|||
| dasatinib [Specialist drug] | Formulary |
NICE TA426 NICE TA425 |
|||
| erdafitinib [Specialist drug] | Restricted |
NICE TA1062 |
|||
| erlotinib [Specialist drug] | Formulary |
NICE TA227 NICE TA258 NICE TA374 NICE TA374 |
|||
| everolimus | Formulary |
NICE TA421 NICE TA432 NICE TA449 |
|||
|
Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481 |
|||||
| fedratinib [Specialist drug] | Restricted |
NICE TA1018 |
|||
| futibatinib [Specialist drug] | Restricted |
NICE TA1005 |
|||
| gefitinib [Specialist drug] | Formulary |
NICE TA192 NICE TA374 |
|||
| gilteritinib [Specialist drug] | Formulary |
NICE TA642 |
|||
| ibrutinib [Specialist drug] | Formulary |
NICE TA429 NICE TA891 NICE TA502 NICE TA795 |
|||
| idelalisib [Specialist drug] | Formulary |
NICE TA359 NICE TA604 |
|||
| imatinib [Specialist drug] | Formulary |
NICE TA326 NICE TA70 NICE TA86 NICE TA209 NICE TA426 NICE TA425 |
|||
| ivosidenib [Specialist drug] | Restricted |
NICE TA948 NICE TA979 |
|||
| ixazomib [Specialist drug] | Formulary |
NICE TA870 |
|||
| lapatinib [Specialist drug] | Non-Formulary |
NICE TA257 |
|||
| larotrectinib [Specialist drug] | Formulary |
NICE TA630 |
|||
| lorlatinib [Specialist drug] | Formulary |
NICE TA628 NICE TA1103 |
|||
| midostaurin [Specialist drug] | Formulary |
NICE TA523 NICE TA728 |
|||
| momelotinib [Specialist drug] | Restricted |
NICE TA957 |
|||
| nilotinib [Specialist drug] | Formulary |
NICE TA426 NICE TA425 |
|||
| nintedanib | Formulary |
NICE TA347 NICE TA379 NICE TA864 NICE TA747 |
|||
| niraparib [Specialist drug] | Formulary |
NICE TA673 NICE TA784 |
|||
| olaparib [Specialist drug] | Restricted |
NICE TA908 NICE TA946 NICE TA962 NICE TA886 NICE TA1040 NICE TA887 NICE TA951 |
|||
| osimertinib [Specialist drug] | Restricted |
NICE TA653 NICE TA654 NICE TA1043 NICE TA1060 |
|||
| palbociclib [Specialist drug] | Formulary |
NICE TA495 NICE TA836 |
|||
| pazopanib [Specialist drug] | Formulary |
NICE TA215 |
|||
| pemigatinib [Specialist drug] | Formulary |
NICE TA722 |
|||
| ponatinib [Specialist drug] | Formulary |
NICE TA451 |
|||
| ribociclib [Specialist drug] | Restricted |
NICE TA496 NICE TA687 NICE TA1086 |
|||
| rucaparib [Specialist drug] | Formulary |
NICE TA1007 NICE TA1055 |
|||
| ruxolitinib | Formulary |
NICE TA386 NICE TA921 NICE TA1054 |
|||
| sorafenib [Specialist drug] | Formulary |
NICE TA178 NICE TA474 NICE TA535 |
|||
| sotorasib [Specialist drug] | Restricted |
NICE TA781 |
|||
| sunitinib [Specialist drug] | Formulary |
NICE TA169 NICE TA179 NICE TA178 NICE TA449 |
|||
| talazoparib [Specialist drug] | Restricted |
NICE TA952 |
|||
| temsirolimus [Specialist drug] | Formulary |
NICE TA178 |
|||
| tepotinib [Specialist drug] | Restricted |
NICE TA789 |
|||
| vemurafenib [Specialist drug] | Formulary |
NICE TA269 |
|||
| venetoclax [Specialist drug] | Restricted |
NICE TA561 NICE TA663 NICE TA796 NICE TA765 NICE TA787 |
|||
| zanubrutinib [Specialist drug] | Restricted |
NICE TA833 NICE TA931 NICE TA1001 NICE TA1081 |
|||
| Malignant disease / Cytotoxic responsive malignancy | |||||
| azacitidine [Specialist drug] | Restricted |
NICE TA218 NICE TA399 NICE TA827 |
|||
| bendamustine hydrochloride [Specialist drug] | Formulary |
NICE TA216 NICE TA472 |
|||
| bexarotene [Specialist drug] | Non-Formulary | ||||
| bleomycin [Specialist drug] | Restricted | ||||
| busulfan [Specialist drug] | Restricted | ||||
| cabazitaxel [Specialist drug] | Formulary |
NICE TA391 |
|||
| capecitabine [Specialist drug] | Restricted |
NICE TA263 NICE TA212 NICE TA191 NICE TA61 NICE TA100 |
|||
| carboplatin [Specialist drug] | Restricted |
NICE TA284 NICE TA285 |
|||
| carmustine [Specialist drug] | Restricted |
NICE TA121 |
|||
| chlorambucil [Specialist drug] | Restricted |
NICE TA343 NICE TA344 |
|||
| chlormethine [Specialist drug] | Restricted |
NICE TA720 |
|||
| Cutaneous gel | |||||
| Ledaga (Recordati Rare Diseases UK Ltd) | Restricted | ||||
| cisplatin [Specialist drug] | Restricted | ||||
| cladribine | Restricted |
NICE TA616 NICE TA1053 |
|||
| crisantaspase [Specialist drug] | Restricted | ||||
| cyclophosphamide | Restricted | ||||
| cytarabine [Specialist drug] | Restricted | ||||
| dacarbazine [Specialist drug] | Restricted | ||||
| daunorubicin [Specialist drug] | Restricted | ||||
| docetaxel [Specialist drug] | Restricted |
NICE TA101 NICE TA509 |
|||
| doxorubicin hydrochloride [Specialist drug] | Restricted |
NICE TA389 NICE TA465 |
|||
| epirubicin hydrochloride [Specialist drug] | Restricted | ||||
| eribulin [Specialist drug] | Formulary |
NICE TA423 NICE TA515 |
|||
| etoposide [Specialist drug] | Restricted | ||||
| fludarabine phosphate [Specialist drug] | Restricted |
NICE TA119 NICE TA29 |
|||
| fluorouracil | Restricted | ||||
| gemcitabine [Specialist drug] | Restricted |
NICE TA25 NICE TA116 NICE TA285 NICE TA389 NICE TA476 |
|||
| hydroxycarbamide | Restricted | ||||
| idarubicin hydrochloride [Specialist drug] | Restricted | ||||
| ifosfamide [Specialist drug] | Restricted | ||||
| irinotecan hydrochloride [Specialist drug] | Restricted |
NICE TA440 |
|||
| melphalan [Specialist drug] | Restricted | ||||
| mercaptopurine | Restricted | ||||
| methotrexate | Formulary | ||||
| mitomycin [Specialist drug] | Restricted | ||||
| mitotane [Specialist drug] | Non-Formulary | ||||
| mitoxantrone [Specialist drug] | Restricted | ||||
| oxaliplatin [Specialist drug] | Formulary |
NICE TA100 NICE TA93 |
|||
| paclitaxel [Specialist drug] | Restricted |
NICE TA55 NICE TA284 NICE TA389 NICE TA476 |
|||
| panobinostat [Specialist drug] | Formulary |
NICE TA380 |
|||
| pemetrexed [Specialist drug] | Restricted |
NICE TA124 NICE TA181 NICE TA402 NICE TA190 NICE TA135 |
|||
| pentostatin [Specialist drug] | Restricted | ||||
| pixantrone [Specialist drug] | Formulary |
NICE TA306 |
|||
| procarbazine [Specialist drug] | Restricted | ||||
| raltitrexed [Specialist drug] | Restricted | ||||
| temozolomide [Specialist drug] | Formulary |
NICE TA23 NICE TA121 |
|||
| tioguanine [Specialist drug] | Restricted | ||||
| topotecan [Specialist drug] | Formulary |
NICE TA183 NICE TA184 NICE TA389 |
|||
| trabectedin [Specialist drug] | Formulary |
NICE TA185 NICE TA389 |
|||
| treosulfan [Specialist drug] | Restricted |
NICE TA640 |
|||
| tretinoin [Specialist drug] | Restricted | ||||
| trifluridine with tipiracil [Specialist drug] | Restricted |
NICE TA405 NICE TA1008 NICE TA852 |
|||
| vinblastine sulfate [Specialist drug] | Restricted | ||||
| vincristine sulfate [Specialist drug] | Restricted | ||||
| vindesine sulfate [Specialist drug] | Restricted | ||||
| vinorelbine [Specialist drug] | Restricted | ||||
| Malignant disease / Cytotoxic drug-induced side effects | |||||
| dexrazoxane | Restricted | ||||
| folinic acid | Restricted |
NICE TA212 |
|||
| mesna | Restricted | ||||
| Malignant disease / Hyperuricaemia associated with cytotoxic drugs | |||||
| rasburicase | Formulary | ||||
| Malignant disease / Hormone responsive malignancy | |||||
| abiraterone acetate | Restricted |
NICE TA259 NICE TA387 NICE TA1110 |
|||
| apalutamide | Formulary |
NICE TA740 NICE TA741 |
|||
| bicalutamide | Formulary | ||||
| cyproterone acetate | Formulary | ||||
| darolutamide | Restricted |
NICE TA660 NICE TA903 NICE TA1109 |
|||
| degarelix | Restricted |
NICE TA404 |
|||
| diethylstilbestrol | Formulary | ||||
| enzalutamide | Formulary |
NICE TA316 NICE TA377 NICE TA580 NICE TA712 |
|||
| ethinylestradiol | Formulary | ||||
| flutamide | Formulary | ||||
| goserelin | Formulary | ||||
| lanreotide | Restricted | ||||
| medroxyprogesterone acetate | Formulary | ||||
| megestrol acetate | Formulary | ||||
| norethisterone | Formulary | ||||
| octreotide | Formulary | ||||
| Solution for injection | |||||
| Octreotide (Non-proprietary) | Non-Formulary | ||||
| pasireotide | Non-Formulary | ||||
| relugolix | Restricted |
NICE TA995 |
|||
| Malignant disease / Hormone responsive breast cancer | |||||
| anastrozole | Formulary | ||||
| elacestrant | Restricted |
NICE TA1036 |
|||
| exemestane | Formulary | ||||
| fulvestrant | Restricted |
NICE TA503 |
|||
| Solution for injection | |||||
| Faslodex (AstraZeneca UK Ltd) | Non-Formulary | ||||
| letrozole | Formulary | ||||
| tamoxifen | Formulary | ||||
| toremifene | Non-Formulary | ||||
| Malignant disease / Secondary bone metastases and hypercalcaemia | |||||
| denosumab | Formulary |
NICE TA204 NICE TA265 |
|||
| ibandronic acid | Formulary |
NICE TA464 |
|||